ARTICLE | Company News
Eurogentec, Geymonat S.p.A., Roche, ThromboGenics N.V cardiovascular news
January 22, 2007 8:00 AM UTC
The EU granted E2 million ($2.6 million) to the Vasoplus research consortium, which consists of THR, Geymonat, Eurogentec, ROG's Roche Diagnostics unit, the Italian National Research Council, the Univ...